UNC Health Medication Formulary
Add Formweb to your mobile device
UNC Health Medication Formulary
Search results for:
dantrolene
dantrolene
| Drug Name | Form | Strength | ARHS | Blue Ridge | Caldwell | Chatham | Johnston | Lenoir | Medical Center | Nash | Pardee | Rex | Rockingham | Southeastern | Wayne | Youth Behavioral Health |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dantrolene | CAPSULE, ORAL | 25 mg | ||||||||||||||
| Dantrolene (Revonto) | POWDER FOR INJECTION, INTRAVENOUS | 20 mg | ||||||||||||||
| Dantrolene (Ryanodex) | POWDER FOR INJECTION, INTRAVENOUS | 250 mg |
Last updated: Jul. 18, 2023
- Black Box Warning: Hepatotoxicity
UNC Health
System Formulary Restriction:
Use of Ryanodex injection is restricted to initial management of malignant hyperthermia crisis (ie, Ryanodex cannot be used for post-crisis doses)
UNC Health IV Compendium Guideline
Johnston
Malignant Hyperthermia Cart Policy
Malignant Hyperthermia Treatment Policy
Med Center
UNC Medical Center Formulary Restrictions - Ryanodex
Rex
Antidotes and Poisons Guideline
Malignant Hyperthermia Crisis Management Protocol